|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.80 USD | +5.80% |
|
+11.97% | +151.67% |
| 06-18 | InTest Corporation Approves the Election of Karl E. Johnsen to the Board of Directors | CI |
| 05-05 | InTest Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.04 | 6.26 | 5.33 | 2.17 | -1.18 | |||||
Return on Total Capital | 9.99 | 7.93 | 6.49 | 2.61 | -1.46 | |||||
Return On Equity % | 14.63 | 14.13 | 11.59 | 2.95 | -2.48 | |||||
Return on Common Equity | 14.63 | 14.13 | 11.59 | 2.95 | -2.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 48.57 | 45.74 | 46.21 | 43.63 | 42.98 | |||||
SG&A Margin | 29.49 | 30.12 | 31.57 | 33.27 | 34.27 | |||||
EBITDA Margin % | 15.06 | 12.17 | 10.99 | 6.8 | 1.49 | |||||
EBITA Margin % | 14.28 | 11.48 | 10.16 | 5.77 | 0.41 | |||||
EBIT Margin % | 12.58 | 9.18 | 8.47 | 3.82 | -2.53 | |||||
Income From Continuing Operations Margin % | 8.58 | 7.24 | 7.58 | 2.21 | -2.22 | |||||
Net Income Margin % | 8.58 | 7.24 | 7.58 | 2.21 | -2.22 | |||||
Net Avail. For Common Margin % | 8.58 | 7.24 | 7.58 | 2.21 | -2.22 | |||||
Normalized Net Income Margin | 7.82 | 5.43 | 5.6 | 2.42 | -1.3 | |||||
Levered Free Cash Flow Margin | 9.47 | -2.36 | 11.99 | -4.41 | 3.85 | |||||
Unlevered Free Cash Flow Margin | 9.47 | -2.02 | 12.34 | -4 | 4.1 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.02 | 1.09 | 1.01 | 0.91 | 0.75 | |||||
Fixed Assets Turnover | 9.79 | 13.34 | 14.44 | 11.17 | 7.82 | |||||
Receivables Turnover (Average Receivables) | 6.8 | 6.19 | 6.26 | 5.48 | 4.11 | |||||
Inventory Turnover (Average Inventory) | 4.29 | 3.58 | 3.11 | 3.14 | 2.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.08 | 2.23 | 3.53 | 2.47 | 2.2 | |||||
Quick Ratio | 1.5 | 1.29 | 2.61 | 1.54 | 1.12 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | -0.05 | 0.67 | 0.12 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 53.69 | 58.97 | 58.3 | 66.75 | 88.8 | |||||
Days Outstanding Inventory (Average Inventory) | 85.03 | 102 | 117.37 | 116.57 | 164.26 | |||||
Average Days Payable Outstanding | 24.95 | 29.15 | 36.92 | 30.75 | 50.3 | |||||
Cash Conversion Cycle (Average Days) | 113.77 | 131.82 | 138.75 | 152.57 | 202.76 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.78 | 34.63 | 18.14 | 26.1 | 16.37 | |||||
Total Debt / Total Capital | 32.78 | 25.72 | 15.35 | 20.7 | 14.07 | |||||
LT Debt/Equity | 38.8 | 25.78 | 11.88 | 16.59 | 8.5 | |||||
Long-Term Debt / Total Capital | 26.08 | 19.15 | 10.06 | 13.16 | 7.3 | |||||
Total Liabilities / Total Assets | 47.24 | 40.98 | 28.59 | 34.47 | 31.52 | |||||
EBIT / Interest Expense | - | 16.88 | 15.37 | 5.9 | -6.39 | |||||
EBITDA / Interest Expense | - | 24.62 | 22.32 | 12.74 | 9.61 | |||||
(EBITDA - Capex) / Interest Expense | - | 22.47 | 20.42 | 11.17 | 5.98 | |||||
Total Debt / EBITDA | 1.9 | 1.44 | 1.15 | 2.42 | 3.93 | |||||
Net Debt / EBITDA | 0.39 | 0.58 | -1.83 | 0.58 | 0.64 | |||||
Total Debt / (EBITDA - Capex) | 2.05 | 1.58 | 1.26 | 2.75 | 6.31 | |||||
Net Debt / (EBITDA - Capex) | 0.42 | 0.63 | -2 | 0.66 | 1.02 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 57.7 | 37.64 | 5.54 | 5.99 | -12.9 | |||||
Gross Profit, 1 Yr. Growth % | 71.03 | 29.63 | 6.62 | 0.08 | -14.21 | |||||
EBITDA, 1 Yr. Growth % | 477.98 | 11.18 | -4.64 | -34.28 | -81.05 | |||||
EBITA, 1 Yr. Growth % | 674.38 | 10.69 | -6.57 | -39.85 | -93.75 | |||||
EBIT, 1 Yr. Growth % | 3.12K | 0.39 | -2.63 | -52.16 | -157.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -913.74 | 16.17 | 10.41 | -69.05 | -187.41 | |||||
Net Income, 1 Yr. Growth % | -913.74 | 16.17 | 10.41 | -69.05 | -187.41 | |||||
Normalized Net Income, 1 Yr. Growth % | 3.24K | -4.49 | 8.9 | -54.25 | -146.93 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -855.56 | 14.71 | 1.28 | -69.89 | -188.27 | |||||
Accounts Receivable, 1 Yr. Growth % | 96.04 | 28.3 | -14.33 | 62.28 | -12.22 | |||||
Inventory, 1 Yr. Growth % | 72.06 | 75.43 | -10.97 | 33.59 | 17.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.49 | 3.43 | -8.14 | 86.18 | -8.85 | |||||
Total Assets, 1 Yr. Growth % | 67.51 | 5.93 | 22.5 | 12.95 | -0.64 | |||||
Tangible Book Value, 1 Yr. Growth % | -36.85 | 111.16 | 133.77 | -26.38 | 8.71 | |||||
Common Equity, 1 Yr. Growth % | 22.5 | 18.48 | 48.22 | 3.64 | 3.84 | |||||
Cash From Operations, 1 Yr. Growth % | 233.56 | -112.81 | -1.27K | -76.42 | 91.44 | |||||
Capital Expenditures, 1 Yr. Growth % | 51.06 | 37.32 | -5.42 | 2.56 | 23.26 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 75.84 | -134.08 | -637.38 | -138.93 | -176.18 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 75.84 | -128.97 | -745.94 | -134.37 | -189.26 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 18.29 | 47.33 | 20.53 | 5.77 | -3.92 | |||||
Gross Profit, 2 Yr. CAGR % | 18.77 | 48.9 | 17.57 | 3.3 | -7.34 | |||||
EBITDA, 2 Yr. CAGR % | 53.67 | 153.49 | 2.97 | -20.93 | -64.64 | |||||
EBITA, 2 Yr. CAGR % | 60.08 | 192.78 | 1.69 | -25.03 | -80.61 | |||||
EBIT, 2 Yr. CAGR % | 75.38 | 468.26 | -1.13 | -31.75 | -47.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 77.1 | 207.47 | 13.26 | -41.55 | -47.99 | |||||
Net Income, 2 Yr. CAGR % | 77.1 | 207.47 | 13.26 | -41.55 | -47.99 | |||||
Normalized Net Income, 2 Yr. CAGR % | 73.54 | 464.82 | 1.99 | -29.42 | -53.66 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 75.81 | 194.39 | 7.79 | -44.77 | -48.44 | |||||
Accounts Receivable, 2 Yr. CAGR % | 33.37 | 58.59 | 4.84 | 17.91 | 19.35 | |||||
Inventory, 2 Yr. CAGR % | 33.83 | 73.73 | 24.97 | 9.06 | 25.38 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.87 | 0.94 | -2.53 | 30.77 | 30.27 | |||||
Total Assets, 2 Yr. CAGR % | 31.91 | 33.21 | 13.91 | 17.63 | 5.94 | |||||
Tangible Book Value, 2 Yr. CAGR % | -17.95 | 15.47 | 122.18 | 31.19 | -10.54 | |||||
Common Equity, 2 Yr. CAGR % | 10.58 | 20.48 | 32.52 | 23.95 | 3.74 | |||||
Cash From Operations, 2 Yr. CAGR % | 13.53 | -34.61 | 22.25 | 65.86 | -32.81 | |||||
Capital Expenditures, 2 Yr. CAGR % | 26.62 | 44.03 | 13.96 | -1.51 | 12.43 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -1.31 | -22.42 | 35.33 | 44.63 | -45.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -1.31 | -28.23 | 36.79 | 48.99 | -44.61 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.61 | 24.42 | 31.83 | 15.47 | -0.86 | |||||
Gross Profit, 3 Yr. CAGR % | 1.52 | 22.28 | 33.21 | 11.42 | -2.9 | |||||
EBITDA, 3 Yr. CAGR % | -2.87 | 37.95 | 82.99 | -11.42 | -50.82 | |||||
EBITA, 3 Yr. CAGR % | -2.77 | 41.56 | 100.07 | -14.63 | -67.26 | |||||
EBIT, 3 Yr. CAGR % | -4.03 | 45.62 | 215.63 | -22.38 | -35.51 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 33.85 | 53.88 | 118.54 | -26.51 | -33.16 | |||||
Net Income, 3 Yr. CAGR % | 33.85 | 53.88 | 118.54 | -26.51 | -33.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | -3.83 | 42.22 | 226.3 | -21.93 | -38.39 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 32.85 | 52.48 | 106.28 | -29.54 | -35.43 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16.11 | 31.66 | 29.16 | 21.28 | 6.86 | |||||
Inventory, 3 Yr. CAGR % | 25.42 | 46.46 | 39.03 | 27.78 | 11.86 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 46.87 | 7.02 | -2.18 | 20.94 | 15.95 | |||||
Total Assets, 3 Yr. CAGR % | 15.64 | 22.61 | 29.54 | 13.59 | 11.19 | |||||
Tangible Book Value, 3 Yr. CAGR % | -6.21 | 12.44 | 46.08 | 53.75 | 23.22 | |||||
Common Equity, 3 Yr. CAGR % | 8.53 | 13.15 | 29.1 | 22.1 | 16.85 | |||||
Cash From Operations, 3 Yr. CAGR % | -0.38 | -45.12 | 70.87 | -29.36 | 73.98 | |||||
Capital Expenditures, 3 Yr. CAGR % | -23.4 | 30.09 | 25.19 | 10.03 | 6.14 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -18.42 | -30.66 | 47.89 | -10.67 | 16.8 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -18.42 | -34.17 | 49.29 | -13.69 | 25.6 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.11 | 11.83 | 9.43 | 16.59 | 16.16 | |||||
Gross Profit, 5 Yr. CAGR % | 15.13 | 9.03 | 7.66 | 14.3 | 15.21 | |||||
EBITDA, 5 Yr. CAGR % | 19.46 | 1.34 | -0.58 | 10.42 | -5.23 | |||||
EBITA, 5 Yr. CAGR % | 19.93 | 1.13 | -1.01 | 9.78 | -21.35 | |||||
EBIT, 5 Yr. CAGR % | 18.06 | -1.43 | -2.88 | 7.54 | 53.99 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.34 | 54.06 | 25.2 | 4.48 | 23.07 | |||||
Net Income, 5 Yr. CAGR % | 22.34 | 54.06 | 25.2 | 4.48 | 23.07 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.63 | -2.89 | -1.55 | 7.46 | 49.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.42 | 54.02 | 22.19 | 1.58 | 18.47 | |||||
Accounts Receivable, 5 Yr. CAGR % | 25.19 | 11.76 | 11.46 | 25.98 | 25.14 | |||||
Inventory, 5 Yr. CAGR % | 28.47 | 35.36 | 25.24 | 30.17 | 33.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 55.59 | 42.02 | 24.65 | 15.96 | 9.69 | |||||
Total Assets, 5 Yr. CAGR % | 19.38 | 11.99 | 14.95 | 20.59 | 19.52 | |||||
Tangible Book Value, 5 Yr. CAGR % | -19.72 | 21.06 | 32.43 | 19.59 | 20.06 | |||||
Common Equity, 5 Yr. CAGR % | 7.73 | 10.58 | 17.56 | 17.35 | 18.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 20.37 | -28.13 | 8.13 | -14.59 | 17.63 | |||||
Capital Expenditures, 5 Yr. CAGR % | 24 | 12.87 | -10.21 | 16.39 | 19.92 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.47 | -22.16 | -0.03 | -6.95 | -0.83 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 17.47 | -24.54 | 0.54 | -8.73 | 0.41 |
- Stock Market
- Stocks
- INTT Stock
- Financials InTest Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















